Luye Pharma Group Statistics

Total Valuation

HKG:2186 has a market cap or net worth of HKD 7.34 billion. The enterprise value is 13.10 billion.

Market Cap	7.34B
Enterprise Value	13.10B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2186 has 3.76 billion shares outstanding. The number of shares has increased by 0.89% in one year.

Current Share Class	3.76B
Shares Outstanding	3.76B
Shares Change (YoY)	+0.89%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	27.18%
Float	1.96B

Valuation Ratios

The trailing PE ratio is 14.61 and the forward PE ratio is 12.02.

PE Ratio	14.61
Forward PE	12.02
PS Ratio	1.14
PB Ratio	0.44
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	41.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.41, with an EV/FCF ratio of -28.88.

EV / Earnings	26.09
EV / Sales	2.03
EV / EBITDA	6.41
EV / EBIT	10.84
EV / FCF	-28.88

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.66.

Current Ratio	1.24
Quick Ratio	1.01
Debt / Equity	0.66
Debt / EBITDA	5.38
Debt / FCF	-24.21
Interest Coverage	2.02

Financial Efficiency

Return on equity (ROE) is 4.41% and return on invested capital (ROIC) is 2.96%.

Return on Equity (ROE)	4.41%
Return on Assets (ROA)	2.58%
Return on Invested Capital (ROIC)	2.96%
Return on Capital Employed (ROCE)	6.03%
Revenue Per Employee	1.25M
Profits Per Employee	97,508
Employee Count	5,150
Asset Turnover	0.22
Inventory Turnover	2.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.56% in the last 52 weeks. The beta is 0.79, so HKG:2186's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-34.56%
50-Day Moving Average	2.16
200-Day Moving Average	2.53
Relative Strength Index (RSI)	42.66
Average Volume (20 Days)	51,220,193

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2186 had revenue of HKD 6.45 billion and earned 502.17 million in profits. Earnings per share was 0.13.

Revenue	6.45B
Gross Profit	4.30B
Operating Income	1.21B
Pretax Income	893.07M
Net Income	502.17M
EBITDA	2.01B
EBIT	1.21B
Earnings Per Share (EPS)	0.13

Full Income Statement

Balance Sheet

The company has 6.92 billion in cash and 10.98 billion in debt, giving a net cash position of -4.06 billion or -1.08 per share.

Cash & Cash Equivalents	6.92B
Total Debt	10.98B
Net Cash	-4.06B
Net Cash Per Share	-1.08
Equity (Book Value)	16.76B
Book Value Per Share	4.00
Working Capital	2.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 178.53 million and capital expenditures -632.19 million, giving a free cash flow of -453.66 million.

Operating Cash Flow	178.53M
Capital Expenditures	-632.19M
Free Cash Flow	-453.66M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross margin is 66.72%, with operating and profit margins of 18.75% and 7.79%.

Gross Margin	66.72%
Operating Margin	18.75%
Pretax Margin	13.85%
Profit Margin	7.79%
EBITDA Margin	31.21%
EBIT Margin	18.75%
FCF Margin	n/a

Dividends & Yields

HKG:2186 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.89%
Shareholder Yield	-0.89%
Earnings Yield	6.85%
FCF Yield	-6.18%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2186 has an Altman Z-Score of 1.23. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.23
Piotroski F-Score	n/a